Florida Senate - 2023                        COMMITTEE AMENDMENT
       Bill No. SB 612
       
       
       
       
       
       
                                Ì558772GÎ558772                         
       
                              LEGISLATIVE ACTION                        
                    Senate             .             House              
                  Comm: RCS            .                                
                  03/28/2023           .                                
                                       .                                
                                       .                                
                                       .                                
       —————————————————————————————————————————————————————————————————




       —————————————————————————————————————————————————————————————————
       The Committee on Health Policy (Yarborough) recommended the
       following:
       
    1         Senate Amendment (with title amendment)
    2  
    3         Delete everything after the enacting clause
    4  and insert:
    5         Section 1. This act may be cited as the “Emily Adkins
    6  Prevention Act.”
    7         Section 2. Section 408.0621, Florida Statutes, is created
    8  to read:
    9         408.0621 Blood clot and pulmonary embolism policy
   10  workgroup.—
   11         (1) The Secretary of Health Care Administration, in
   12  conjunction with the State Surgeon General, shall establish a
   13  blood clot and pulmonary embolism policy workgroup.
   14         (2) The workgroup shall:
   15         (a) Identify the aggregate number of people who experience
   16  blood clots and pulmonary embolisms each year in this state.
   17         (b) Identify how data is collected regarding blood clots,
   18  pulmonary embolisms, and adverse health outcomes associated with
   19  these conditions.
   20         (c) Identify how blood clots and pulmonary embolisms impact
   21  the lives of people in this state.
   22         (d) Identify the standards of care for blood clot
   23  surveillance, detection, and treatment.
   24         (e) Identify emerging treatments, therapies, and research
   25  relating to blood clots.
   26         (f) Develop a risk surveillance system to help health care
   27  providers identify patients who may be at a higher risk of
   28  forming blood clots and pulmonary embolisms.
   29         (g) Develop policy recommendations to help improve patient
   30  awareness of blood clot risks.
   31         (h) Develop policy recommendations to help improve
   32  surveillance and detection of patients who may be at a higher
   33  risk of forming blood clots in licensed health care facilities,
   34  including, hospitals, nursing homes, assisted living facilities,
   35  residential treatment facilities, and ambulatory surgical
   36  centers.
   37         (i) Develop policy recommendations relating to guidelines
   38  used that affect the standard of care for patients at risk of
   39  forming blood clots.
   40         (j) Develop policy recommendations relating to providing
   41  patients and their families with written notice of increased
   42  risks of forming blood clots.
   43         (3)(a) The workgroup shall be composed of health care
   44  providers, patients who have experienced blood clots, family
   45  members of patients who have died from blood clots, advocates,
   46  and other interested parties and associations.
   47         (b) The President of the Senate and the Speaker of the
   48  House of Representatives shall each appoint two members to the
   49  workgroup.
   50         (c) Members of the workgroup shall serve without
   51  compensation.
   52         (d) The State Surgeon General shall appoint the chair of
   53  the workgroup.
   54         (e) The chair is authorized to create subcommittees to help
   55  with research, scheduling speakers on important subjects, and
   56  drafting a workgroup report and policy recommendations.
   57         (f) Meetings of the workgroup may be held through
   58  teleconference or other electronic means.
   59         (4)(a) The Secretary of Health Care Administration shall
   60  submit an annual report detailing his or her findings and
   61  recommendations to the Governor, the President of the Senate,
   62  and the Speaker of the House of Representatives.
   63         (b) The Secretary of Health Care Administration shall
   64  submit a final report detailing his or her findings and
   65  recommendations to the Governor, the President of the Senate,
   66  and the Speaker of the House of Representatives by January 4,
   67  2025.
   68         Section 3. This act shall take effect July 1, 2023.
   69  
   70  ================= T I T L E  A M E N D M E N T ================
   71  And the title is amended as follows:
   72         Delete everything before the enacting clause
   73  and insert:
   74                        A bill to be entitled                      
   75         An act relating to the blood clot and pulmonary
   76         embolism policy workgroup; providing a short title;
   77         creating s. 408.0621, F.S.; requiring the Secretary of
   78         Health Care Administration, in conjunction with the
   79         State Surgeon General, to establish a blood clot and
   80         pulmonary embolism policy workgroup; providing for the
   81         duties, membership, and meetings of the workgroup;
   82         requiring the secretary to submit annual reports to
   83         the Governor and the Legislature; requiring the
   84         secretary to submit a final report to the Governor and
   85         the Legislature by a specified date; providing an
   86         effective date.